In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

View Content for:
Display:
  •          
Help with display options.
Results 1-2 of 2 for your search:
Drug:  hafnium oxide-containing nanoparticles NBTXR3
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NBTXR3-101, ID RCB : 2011-A00342-39, NCT01433068

2.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 65 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: NBTXR3-102, ID RCB: 2013-A00706-39, NCT01946867
New Search